In the several years since scientists deciphered the human genome — the so-called instruction book for human life — we are faced with many questions: Will insurance companies or employers discriminate against us if we carry genes that cause costly diseases? Should our goal be genetically perfect children who are immune to disease and intellectually and cosmetically gifted? Are genetically modified foods healthy for us to eat? Join us as a distinguished panel of bioethicists, sociologists and scientists discuss these and other issues related to our post-genomic future.

Panelists

Francis Collins, M.D., Ph.D.
Director of the National Human Genome Research Institute, National Institutes of Health

Troy Duster, Ph.D.
Professor of Sociology, New York University

Ruth Fischbach, Ph.D., MPE
Professor of Bioethics and Director of the Center for Bioethics, Columbia University

Paul Nurse, Ph.D.
President, The Rockefeller University

Moderated by:

Michael Waldholz
Health and Science News Editor, The Wall Street Journal